Ontology highlight
ABSTRACT: Background
Fatigue is a key symptom in patients with systemic lupus erythematosus (SLE), and regulatory bodies recommend its assessment in clinical trials of SLE therapies.Methods
This post hoc pooled analysis of the three BeLimumab In Subjects with Systemic lupus erythematosus (BLISS) Phase 3 randomised, double-blind, parallel-group controlled trials evaluated the measurement properties of the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue. Patients (N = 2520) completed the FACIT-Fatigue every 4 weeks from baseline until the end of each study period. Internal consistency, test-retest reliability, convergent validity, and ability to detect changes in SLE were evaluated for the FACIT-Fatigue.Results
The FACIT-Fatigue showed good internal consistency
SUBMITTER: Rendas-Baum R
PROVIDER: S-EPMC8032841 | biostudies-literature | 2021 Apr
REPOSITORIES: biostudies-literature